A Fluorescent Nanoprobe Could Become A Universal, Noninvasive Method To Identify And Monitor Tumors

  • The nanoprobe detects the low pH of tumors using optical imaging, magnetic resonance and positron emission tomography
  • The probes proved to be biocompatible, which is crucial for biomedical applications
  • The effects are visible within 24 hours when exposed to bright light